TickerFactsScreenerDevelopers

MADRIGAL PHARMACEUTICALS, INC. (MDGL) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $52.05M2009: $44.16M2010: $31.31M2011: $30.07M2012: $81.51M2013: $48.49M2014: $148.1K2015: $306.0K2016: $19.14M2017: $148.63M2018: $57.38M2019: $46.70M2020: $54.00M2021: $36.27M2022: $331.55M2023: $99.92M2024: $100.02M2025: $198.69M$198.69M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$198.69M+98.7%
2024$100.02M+0.1%
2023$99.92M-69.9%
2022$331.55M+814.1%
2021$36.27M-32.8%
2020$54.00M+15.6%
2019$46.70M-18.6%
2018$57.38M-61.4%
2017$148.63M+676.3%
2016$19.14M+6156.5%
2015$306.0K+106.7%
2014$148.1K-99.7%
2013$48.49M-40.5%
2012$81.51M+171.0%
2011$30.07M-3.9%
2010$31.31M-29.1%
2009$44.16M-15.2%
2008$52.05M—